Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

L Barrera, E Cooreman, J de Dieu Iragena, F Drobniewski, P Duda, M Havelkova, S Hoffner, KM Kam, SJ Kim, S Labelle, K Lambregts, V Leimane, P Nunn, A Ramsay, M Raviglione, M Rich, J Ridderhof, F Rodrigues, S Rüsch-Gerdes, M Salfinger, J Scholten, N Selvakumar, T Shinnick, M Shul'gina, G Šķenders, A Sloutsky, P Small, A Van Deun, F Varaine, M Yagui, V Vincent, K Weyer, A Wright, M Zignol
Geneva: World Health Organization; 2008.
WHO Guidelines Approved by the Guidelines Review Committee.
Free Books & Documents
Review

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

L Barrera et al.
Free Books & Documents

Excerpt

This document is intended to provide an interim policy framework for the laboratory component relevant to programmatic implementation of MDR-TB strategies. A detailed technical manual on laboratory methodology, laboratory biosafety and standard operating procedures related to second-line drug-susceptibility testing (DST) is also under preparation.

PubMed Disclaimer

LinkOut - more resources